Ranitidine bismuth citrate (RBC) based triple therapy for 7 days is more effective than RBC plus clarithromycin for 14 days in dyspeptic patients with Helicobacter pylori infection. H. Pylori Lombardy Group (Q42685470)
Jump to navigation
Jump to search
scientific article published on October 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ranitidine bismuth citrate (RBC) based triple therapy for 7 days is more effective than RBC plus clarithromycin for 14 days in dyspeptic patients with Helicobacter pylori infection. H. Pylori Lombardy Group |
scientific article published on October 1998 |
Statements
1 reference
Ranitidine bismuth citrate (RBC) based triple therapy for 7 days is more effective than RBC plus clarithromycin for 14 days in dyspeptic patients with Helicobacter pylori infection. H. Pylori Lombardy Group (English)
1 reference
Cestari R
1 reference
1 October 1998
1 reference
1 reference
12
1 reference
10
1 reference
991-996
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference